Injectable and oral GLP-1 formulations have not been formally studied in nursing populations
GLP-1 medications accelerate colonic transit
On August 1, 2025, the JPML reported there are 2,190 cases pending in MDL -3094 IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
As a practical example in other therapies, some regimens begin with 100 mg and then decrease to 50 mg to achieve a rapid effect, as described on Wikipedia, underscoring how the same principle applies across different medications
This might involve: Working intensively with nutritionists and trainers while on medication (our patients get personalized meal plans that help them build sustainable eating habits for life) Switching to less expensive oral medications for maintenance Gradually tapering while closely monitoring weight Having a clear game plan for what to do if weight starts creeping back The Cyclical Approach Some people (with medical supervision) use these medications in cyclesstaying on until they reach their goal, tapering off, and returning if they regain significant weight
This allows for proper absorption into the bloodstream through the tissue under the tongue